Name | Number of supported studies | Average coverage | |
---|---|---|---|
pro-B cell | 5 studies | 47% ± 13% | |
transit amplifying cell | 3 studies | 28% ± 11% | |
precursor B cell | 3 studies | 47% ± 20% | |
natural killer cell | 3 studies | 29% ± 6% |
Insufficient scRNA-seq data for expression of UHRF1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 93% | 1136.10 | 1678 / 1809 | 91% | 15.53 | 429 / 472 |
lung | 85% | 180.82 | 489 / 578 | 86% | 14.96 | 998 / 1155 |
brain | 73% | 105.10 | 1931 / 2642 | 96% | 25.37 | 677 / 705 |
intestine | 55% | 165.55 | 533 / 966 | 95% | 17.13 | 502 / 527 |
stomach | 54% | 176.18 | 195 / 359 | 95% | 17.29 | 272 / 286 |
esophagus | 48% | 274.27 | 691 / 1445 | 100% | 24.16 | 183 / 183 |
bladder | 43% | 71.14 | 9 / 21 | 93% | 17.40 | 467 / 504 |
breast | 44% | 55.66 | 203 / 459 | 91% | 16.24 | 1014 / 1118 |
uterus | 15% | 24.78 | 26 / 170 | 98% | 33.11 | 449 / 459 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.56 | 29 / 29 |
spleen | 100% | 471.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.92 | 1 / 1 |
peripheral blood | 97% | 971.34 | 897 / 929 | 0% | 0 | 0 / 0 |
ovary | 22% | 34.53 | 40 / 180 | 73% | 7.72 | 314 / 430 |
pancreas | 17% | 18.28 | 56 / 328 | 71% | 6.48 | 126 / 178 |
adrenal gland | 66% | 87.91 | 169 / 258 | 11% | 1.12 | 25 / 230 |
prostate | 59% | 73.30 | 144 / 245 | 13% | 1.02 | 65 / 502 |
liver | 21% | 43.52 | 47 / 226 | 34% | 3.74 | 139 / 406 |
kidney | 34% | 85.30 | 30 / 89 | 17% | 1.42 | 157 / 901 |
thymus | 23% | 30.11 | 151 / 653 | 21% | 10.18 | 126 / 605 |
adipose | 40% | 54.41 | 478 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 32% | 40.33 | 433 / 1335 | 0% | 0 | 0 / 0 |
muscle | 24% | 26.44 | 194 / 803 | 0% | 0 | 0 / 0 |
heart | 14% | 19.68 | 117 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000373 | Biological process | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity |
GO_0016567 | Biological process | protein ubiquitination |
GO_0051247 | Biological process | positive regulation of protein metabolic process |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0044027 | Biological process | negative regulation of gene expression via chromosomal CpG island methylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0031507 | Biological process | heterochromatin formation |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0090307 | Biological process | mitotic spindle assembly |
GO_0035825 | Biological process | homologous recombination |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000792 | Cellular component | heterochromatin |
GO_0005657 | Cellular component | replication fork |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0000785 | Cellular component | chromatin |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0062072 | Molecular function | H3K9me3 modified histone binding |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0042393 | Molecular function | histone binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0044729 | Molecular function | hemi-methylated DNA-binding |
GO_0141055 | Molecular function | histone H3 ubiquitin ligase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0008327 | Molecular function | methyl-CpG binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0140612 | Molecular function | DNA damage sensor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | UHRF1 |
Protein name | RING-type E3 ubiquitin transferase (EC 2.3.2.27) E3 ubiquitin-protein ligase UHRF (EC 2.3.2.27) (RING-type E3 ubiquitin transferase UHRF) (Ubiquitin-like PHD and RING finger domain-containing protein) (Ubiquitin-like-containing PHD and RING finger domains protein) Alternative protein UHRF1 E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Inverted CCAAT box-binding protein of 90 kDa) (Nuclear protein 95) (Nuclear zinc finger protein Np95) (HuNp95) (hNp95) (RING finger protein 106) (RING-type E3 ubiquitin transferase UHRF1) (Transcription factor ICBP90) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (hUHRF1) (Ubiquitin-like-containing PHD and RING finger domains protein 1) |
Synonyms | RNF106 ICBP90 hCG_23497 NP95 |
Description | FUNCTION: Multidomain protein that acts as a key epigenetic regulator by bridging DNA methylation and chromatin modification. Specifically recognizes and binds hemimethylated DNA at replication forks via its YDG domain and recruits DNMT1 methyltransferase to ensure faithful propagation of the DNA methylation patterns through DNA replication. In addition to its role in maintenance of DNA methylation, also plays a key role in chromatin modification: through its tudor-like regions and PHD-type zinc fingers, specifically recognizes and binds histone H3 trimethylated at 'Lys-9' (H3K9me3) and unmethylated at 'Arg-2' (H3R2me0), respectively, and recruits chromatin proteins. Enriched in pericentric heterochromatin where it recruits different chromatin modifiers required for this chromatin replication. Also localizes to euchromatic regions where it negatively regulates transcription possibly by impacting DNA methylation and histone modifications. Has E3 ubiquitin-protein ligase activity by mediating the ubiquitination of target proteins such as histone H3 and PML. It is still unclear how E3 ubiquitin-protein ligase activity is related to its role in chromatin in vivo. Plays a role in DNA repair by cooperating with UHRF2 to ensure recruitment of FANCD2 to interstrand cross-links (ICLs) leading to FANCD2 activation. Acts as a critical player of proper spindle architecture by catalyzing the 'Lys-63'-linked ubiquitination of KIF11, thereby controlling KIF11 localization on the spindle . . FUNCTION: Multi domain E3 ubiquitin ligase that also plays a role in DNA methylation and histone modifications. . FUNCTION: Multi domain E3 ubiquitin ligase that also plays a role in DNA methylation and histone modifications. . FUNCTION: Multi domain E3 ubiquitin ligase that also plays a role in DNA methylation and histone modifications. . |
Accessions | A0A087WTW0 ENST00000622802.4 ENST00000620565.4 ENST00000650932.1 [Q96T88-1] A0A087WVR3 ENST00000615884.4 [Q96T88-1] ENST00000613817.4 L8ECE3 A0A087WWG9 ENST00000616255.1 [Q96T88-1] Q96T88 ENST00000624301.3 [Q96T88-1] ENST00000612630.4 [Q96T88-1] |